We developed an antibody specific to f3-amy loid precursor protein (f3APP) fragments possessing the exact amino terminus of the f3-amyloid peptide and ex amined its induction in postischemic hippocampus, In control hippocampus, this APP fragment was lightly ob served in pyramidal neurons of CA sectors and dentate granule cells, Transient forebrain ischemia enhanced ac cumulation of the APP fragment in CAl pyramidal neu rons, Seven days after the ischemia, while the APP frag ment was still observed in dentate granule cells and CA3 Address correspondence and reprint requests to Dr. M. Yokota at Department of Neurosurgery, Hyogo College of Med icine, Mukogawa-cho I-I, Nishinomiya, Hyogo 663, Japan.
Transient global forebrain ischemia in rodents in duces selective degeneration affecting hippocampal CAl and CA4 neurons with relative sparing of CA3 neurons and dentate granule cells. Although the de generation of CA4 neurons begins within hours after the ischemic insult, CAl neurons remain intact for up to 2 days and then degenerate (delayed neuronal death) (Kirino, 1982) . The molecular mechanisms responsible for differential neuronal vulnerability to ischemic injury are incompletely understood (Schmidt-Kastner and Freund, 1991) . In the previ ous study, we showed that an amyloidogenic pro cess was induced in the early phase of postischemic hippocampus (Saido et ai., 1994) . Here we exam ined the detailed distribution of the cytotoxic frag ment of the (3-amyloid precursor protein «(3APP) in neurons, it disappeared in dead CAl neurons. While as trocytes did not show in any immunoreactivity through out the experiment. those in the CAl sector showed mod erate immunoreactivity 7 days after the ischemia. The APP fragment has a cytotoxic effect on cultured neurons. These results suggest that the accumulation of the cyto toxic APP fragment in CAl neurons may play a role in the development of delayed neuronal death after the ischemic insult. Key Words: Alzheimer's disease-f3-Amyloid pep tides-Cerebral ischemia-Hippocampus.
the ischemic hippocampus and the role of its accu mulation in development of the delayed neuronal death of CAl neurons.
The antibody specific for the amino terminus of (3-amyloid peptide (A(3) was produced and its char acteristics were described in a previous study (Saido et aI., 1994) . This antibody (Ab-9204) recog nizes both A(3 and the COO II terminal fragment of (3APP consisting of 99 or 100 amino acid residues (APP-CI00), but not intact (3APPs «(3APP695, (3APP751, and (3APP770) or the physiologically se creted form of (3APP (Fig. 1 ).
MATERIALS AND METHODS
Adult female Mongolian gerbils weighing 50-70 g (Ja pan Clea) housed under diurnal lighting conditions and allowed food and water ad libitum were anesthetized dur ing the ischemia by diethyl ether and room air. Body temperature was maintained at 3�37°C with a homeo thermic heating blanket (CMA, Stockholm, Sweden) dur ing the anesthesia. Following a midline cervical incision, both common carotid arteries (CCAs) were dissected in 40 gerbils and occluded with small aneurysmal clips. Af ter a lO-min occlusion, the clips were removed to allow recirculation. In 40 sham-operated animals, CCAs were Schematic diagram of the f3-amyloid precursor pro tein (f3APP). Epitope of the novel antibody (Ab-9204) used in the present study is hexamer peptide, DAEFRC (asterisk), in N-terminus of f3-amyloid peptide (Af3). Ab-2904 recognizes Af3 and APP-C100, but not f3APP695, f3APP751, BPP770, or the secreted form of f3APP.
dissected but not occluded. Four animals from eac;h group (ischemic and sham) were killed at intervals of 4 h, I day, 2 days, 3 days, and 7 days after recirculation. At each time point, the animals were euthanized with an overdose of sodium pentobarbital (60 mg/kg i.p. ) and then perfused at 4°C through the ascending aorta with phos phate-buffered saline (PBS), followed by 2% paraformal dehyde in 0.1 M phosphate buffer (pH 7. 4) at 4°C for immunohistochemical study. The perfused brains were removed and fixed with the same fixative for 24 h. Next the brains were immersed in PBS containing 10-20% su crose for 24 h and processed for immunohistochemistry. To assess tissue architecture, 5-f-Lm sections from each hippocampus were prepared after the fixation and stained for cresyl violet.
Immunohistochemical study was performed essentially as previously described. The brain was coronally sec tioned at 20 f-Lm on a cryostat. The sections were incu bated for 15 min at room temperature with 0.3% H202 in PBS followed by 3% normal goat serum in PBS for 20 min. They were then incubated for 24 h at 4°C with a 1 :500 dilution of Ab-9204. The sections were incubated for 2 h in biotinylated anti-rabbit IgG made in goat (Vectastain, ABC kit) and then for 2 h with avidin-biotin peroxidase complex at room temperature. Immunolabel was visualized with 0. 015% diaminobenzidine tetrahydro chloride (DAB) and 0.003% H202 in 50 mM Tris-HCl buffer (pH 7.6).
To specify the glial cell types, one of the two serial thin (4-f-Lm) sections of the hippocampus on day 7 was pro cessed for glial fibrillary acidic protein (GFAP) staining as described previously (Yokota et aI., 1994) , and the other section was processed for APP-CI00 staining. For GFAP staining, sections were treated in methanol containing 0.3% hydrogen peroxide. Sections were incubated in 10% normal goat serum followed by incubation in monoclonal mouse anti-human GFAP (Dako) diluted I: 100 for 24 h at room temperature. Then sections were incubated in per oxidase-conjugated goat anti-mouse IgG. Sections were J Cereb Blood Flow Metab, Vol. 16, No.6, 1996 incubated in DAB as described already. Additionally, double-immunolabeling histochemistry for APP-C 100 and GF AP was performed to clarify colocalization of the both antigens in astrocytes. At first, sections were immuno stained by Ab-9204 and visualized with DAB as de scribed. Then the sections were incubated in monoclonal mouse anti-human GF AP and followed by incubation in peroxidase-conjugated goat anti-mouse IgG. GFAP was visualized by 4-chloro-l-naphthol.
For immunoblot analysis, three sham-treated animals and another three animals treated with 10-min ischemia were perfused with PBS at 1 day after operation. The hippocampus was dissected under a surgical microscope, immersed in liquid nitrogen, and remained frozen at -85°C until further processed. The collected samples were homogenized in the solubilization buffer for sodium dodecyl sulfate polyacrylamide gel electrophoresis, and after brief sonication and heat treatment, aliquots were subjected to Western blot analysis, Western blotting was performed by using Ab-9204 as described in the previous study (Saido et aI., 1992) , Each immunolabeled band was densitometrically quantitated by a videodensitometry system (ACI Japan) and expressed as percentage of sham density. To establish the specificity of Ab-9204, an im munoabsorption test was done. Briefly, before applying Ab-9204 to electroblotted polyvinylidene difluoride mem brane, Ab-9204 was mixed with 40 f-LM APP-CI00 at 37°C for I h and centrifuged at 10,000 g for I h. Then the supern;ttant was applied to the membrane,
The animals were carefully handled in a humane fash ion, and our experimental protocols met the U. S. Public Health Service standards (Guide for the Care and Use of Laboratory Animals, NIH, 1985) .
RESULTS
Complete ischemia of the forebrain for 10 min produced consistent neuronal degeneration in the hippocampal region in all animals surviving at 7 days after the ischemic insult but not in the animals killed before 24 h after the insult. All CAl pyramidal neurons were affected bilaterally, and neurons in CA213 and granule cells in the dentate gyrus were morphologically intact.
In the sham-treated hippocampus, perikarya and dendrites of CA pyramidal neurons and dentate granule cells were lightly stained with Ab-9204 ( Figs. 2A and 3A) . Four hours after the ischemia, the immunoreactivity of the neurons in all CA sec tors and dentate gyrus was significantly enhanced (Fig. 2B) , especially in the CAl pyramidal neurons (Fig. 3B ). APP-CIOO shows granule-like accumula tion in the perikarya of CAl neurons 1 day after the ischemia (Fig. 3C) , while the other neurons showed a homogeneous distribution (Fig. 2C ). This granule like accumulation was observed in CAl neurons un til 2 days after the ischemia but not in the other neurons. In the medial part of the CAl sector, py ramidal neurons were dead and lost immunoreac tivity 3 days after the ischemia. Seven days after the ischemia, all CAl pyramidal neurons were dead and lost immunoreactivity (Fig. 3D) , while CA3 neurons and dentate granule cells still kept moderate immu noreactivity (Fig. 2D ). While glial cells did not show any immunoreactivity throughout the experiment, those in the CAl sector showed moderate immuno reactivity 7 days after the ischemia (Fig. 3D) . These glial cells proved to be astrocytes by GFAP staining in serial section (Fig. 3E ). In the section stained by double immunolabeling, astrocytes showed both APP-CIOO and GFAP immunoreactivities (data not shown). Each group showed consistent tendency of immunohistochemical pattern among animals ex cept for two: One animal killed 4 h after ischemia showed little immunoreactivity as did sham-treated animals. One animal killed 1 day after ischemia showed only enhanced immunoreactivity in whole hippocampus but not granule-like accumulation.
The immunoblot study demonstrated that the im munoreactive substance in our immunohistochemi cal study using Ab-9204 was not Aj3 (4 kDa) but APP-CIOO (16 kDa), and I day after the ischemia, its expression was significantly enhanced (Fig. 4A ) (% of sham density = 317 ± 35%; mean ± SD). The immunoreactivity on the Western blotting was com pletely eliminated by absorbing the Ab-9204 by ex cessive APP-CIOO (Fig. 4B) .
DISCUSSION
Deposition of Aj3 in the form of neuritic plaques is one of the major pathological features of Alzhei mer's disease (Mattson et aI., 1993a; Mullan and Crawford, 1993; Selkoe, 1993) , although Aj3containing neuritic plaques are observed in other l'
High power photomicrograph of CA1 sector. In sham animals, CA1 neurons showed light and homogeneous f3-amyloid precursor protein (APP)-C1 00 immunoreactivity as well as neurons of the other CA sectors and dentate granule cells (A). Four hours after ischemia, immunoreactivity of APP-C100 was significantly enhanced (8). One day later, APP-C100 showed granule-like aggregation in CA1 neurons (e). Seven days later, glial cells (arrows) showed moderate immunoreactivity of APP-C1 00 (D). Serial sections of D were stained with anti-glial fibrillary acidic protein (GFAP) anti body, and the glial cells also showed heavy GFAP immuno reactivity (E). Bar = 50 f.Lm (A), (B); 100 f.Lm (C), (D).
pathological conditions such as Down syndrome (Rumble et aI., 1989) . The transmembrane glyco protein j3APP is enzymatically processed by a-secretase and liberates the physiologically se creted form from the cells. Alternative processing of j3APP by j3-secretase can liberate Aj3 comprising 40-42 amino acids (Saido et aI., 1995) . APP-CIOO, which spans Aj3 and cytoplasmic domains of the C-terminal fragment, is generated in embryonal carcinoma cells with full-length APP cDNA (Y oshikawa, 1993) . The physiologically secreted form of j3APP has protective effect against ischemic or excitotoxic insults (Mattson et aI., 1993b) . On the other hand, aggregated forms of Aj3 and possibly APP-C 100 have a neurotoxic effect (Maruyama et aI.. 1990; Pike et aI., 1993; Seubert et aI., 1993) . A recent study revealed that cultured brain cells se crete j3APP cleaved at the amino terminus of the Aj3 (Seubert et aI., 1993) . Here we demonstrate for the first time that j3APP cleaved at the amino terminus of the Aj3 (APP-CI00) accumulates in vivo and is enhanced under the pathological condition of cere bral ischemia. It may be difficult to clarify the source of the APP-CIOO. However, Maruyama et ai. (1990) demonstrated that APP-CI00 is anchored on plasma membrane in COS cells overexpressing APP-C I 00 and it cannot be released to the extracel lular space before cell death. In our study, signifi cant accumulation of APP-C 100 was observed in CAl neurons I day after the ischemia when the neu rons are still alive. Taken together, APP-C 100 in CAl neurons seems to be produced in these neu rons. Because a small amount of APP-ClOO was observed in the neurons of sham-treated animals, it might have a physiological function as does Af3 in the cultured neurons (Yanker et aI., 1990) . After the ischemic insult, accumulation of APP-C 100 was en hanced in the hippocampal neurons. This may be secondary to neuronal degeneration. Ten minutes of forebrain ischemia induces delayed neuronal death in CAl neurons, but the neurons are morpho logically intact 24 h after the insult. Therefore, gran ule-like aggregation of APP-C 100 possibly takes place as a primary event. Tomimoto et al. (1994) demonstrated that the secreted form of f3APP, which has a neuroprotective effect, accumulates in CA3 neurons after global forebrain ischemia but not in CAl neurons. In our study, neurotoxic APP-ClOO accumulated in neurons of all CA sectors and den tate granule cells. Accumulation of these two sub stances with opposite effects may produce selective vulnerability of hippocampal neurons after isch emia. Pike et al. (1991) demonstrated that the ag gregated but not the monomeric form of Af3 showed neurotoxicity in rat hippocampal cultures. In the present study, granule-like aggregation of APP ClOO was observed only in CAl neurons affected by ischemic insult. In the other neuronal cells, APP ClOO showed homogeneous distribution in the perikarya and dendrites throughout the experiment. While the relationship between APP-CIOO and neu-rotOXIClty still needs further documentation, this difference of APP-C I 00 conformations may play a role in development of delayed neuronal death. In astrocytes of the CA 1 sector, accumulation of APP C 100 was observed 7 days after ischemia. In the chronic stage, �21 days later, glial cells proliferated in the CAl sector. Therefore, accumulation of APP ClOO in astrocytes does not result in cell death of the astrocyte. APP-C 100 may have a different bio logical effect in glia than in neurons.
Our results demonstrate that an ischemic insult modifies amyloidogenic APP processing in hippo campal neurons that display delayed cell death. This animal model may provide a clue to under standing the etiology of Alzheimer's disease and may have a potential role in the development of amyloid-inhibitory therapeutics.
